We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$187B
$150M 0.68%
1,191,380
-478,908
-29% -$63.1M
WDC icon
27
Western Digital
WDC
$169B
$138M 0.62%
216,293
+85,304
+65% +$41.5M
HD icon
28
Home Depot
HD
$320B
$134M 0.6%
379,826
+71,440
+23% +$23.2M
GEV icon
29
GE Vernova
GEV
$251B
$133M 0.6%
113,685
-17,305
-13% -$17.7M
TSLA icon
30
Tesla
TSLA
$1.4T
$132M 0.59%
313,960
+20,560
+7% +$8.18M
MRVL icon
31
Marvell Technology
MRVL
$201B
$132M 0.59%
441,931
-269,816
-38% -$54.1M
AMGN icon
32
Amgen
AMGN
$236B
$131M 0.59%
362,985
-32,366
-8% -$11.1M
JNJ icon
33
Johnson & Johnson
JNJ
$663B
$129M 0.58%
510,174
-288,641
-36% -$67.3M
UNH icon
34
UnitedHealth
UNH
$356B
$128M 0.58%
309,295
+76,456
+33% +$28.3M
NOW icon
35
ServiceNow
NOW
$146B
$124M 0.56%
1,246,863
+83,303
+7% +$8.25M
REGN icon
36
Regeneron Pharmaceuticals
REGN
$85.2B
$122M 0.55%
195,674
+9,286
+5% +$6.32M
ADI icon
37
Analog Devices
ADI
$176B
$118M 0.53%
296,457
+11,262
+4% +$4.46M
XYL icon
38
Xylem
XYL
$24.7B
$116M 0.52%
982,258
+7,387
+0.8% +$853K
CRWD icon
39
CrowdStrike
CRWD
$218B
$109M 0.49%
570,180
+17,656
+3% +$2.51M
CDNS icon
40
Cadence Design Systems
CDNS
$80.6B
$105M 0.47%
278,728
+6,227
+2% +$2.18M
RVMD icon
41
Revolution Medicines
RVMD
$45B
$104M 0.47%
556,392
-24,285
-4% -$3.55M
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$138B
$99M 0.45%
199,505
-29,410
-13% -$13M
WAB icon
43
Wabtec
WAB
$47.8B
$98M 0.44%
364,034
+32,542
+10% +$8.6M
DDOG icon
44
Datadog
DDOG
$76.5B
$97.7M 0.44%
375,744
+13,309
+4% +$2.47M
PG icon
45
Procter & Gamble
PG
$340B
$96.2M 0.43%
656,423
-52,699
-7% -$7.67M
CSCO icon
46
Cisco
CSCO
$431B
$95.7M 0.43%
815,855
-56,168
-6% -$5.87M
ALNY icon
47
Alnylam Pharmaceuticals
ALNY
$35.6B
$94.6M 0.43%
314,512
+90,182
+40% +$27.2M
MDB icon
48
MongoDB
MDB
$29.7B
$94.2M 0.42%
280,581
+67,514
+32% +$20.2M
MS icon
49
Morgan Stanley
MS
$342B
$92M 0.41%
440,328
-21,559
-5% -$4.27M
CRDO icon
50
Credo Technology Group
CRDO
$32.1B
$88.9M 0.4%
327,059
-62,047
-16% -$12.3M

Similar funds

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.